Allergen immunotherapy

9 marketed 12 in Phase 3 1 in Phase 2

This page covers all Allergen immunotherapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Grass pollen allergens (recombinant), Dust mite allergen proteins (Der p 1, Der p 2, and related epitopes), Birch pollen allergens (Bet v 1 and related epitopes).

Targets

Grass pollen allergens (recombinant) · Dust mite allergen proteins (Der p 1, Der p 2, and related epitopes) · Birch pollen allergens (Bet v 1 and related epitopes)

Marketed (9)

Phase 3 pipeline (12)

Phase 2 pipeline (1)